In brief

BMJ 2007; 335 doi: (Published 27 September 2007) Cite this as: BMJ 2007;335:636

US Congress reauthorises FDA for five years: President Bush is expected to sign a bill that raises by 25% the fees paid by drug companies for the Food and Drug Administration to review new drugs. It also sets up a computerised surveillance system for adverse events that uses data from pharmacies and insurance companies. (See BMJ 2007;335:471 doi: 10.1136/bmj.39316.442836.DB.)

HIV vaccine trial is ended: Merck has halted trials of …

View Full Text

Log in

Log in through your institution


* For online subscription